Medical Treatments for Prostate Cancer

There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.

Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy.

The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.

brachytherapy cancer prostate
California Endocurietherapy Brachytherapy Cancer Center
cancer patients may consider brachytherapy prostate seed implants.

Prostate Cancer Brachytherapy Prostate Seed Implant
The Prostate cancer guide aims to give the visitor in depth information on prevention, management, brachytherapy, and other treatments, of the condition.

Prostate Cancer
Current and accurate information for patients about Prostate Cancer. therapy - Also called "brachytherapy," it puts radiation right where the cancer is.

BRACHYTHERAPY FOR PROSTATE CANCER
Brachytherapy treatment for prostate cancer involves the insertion of pellets which deliver a radiation dose. This article outlines what is involved

Gloucestershire Prostate Cancer (Brachytherapy Unit) Trust
Gloucestershire Prostate Cancer and Brachytherapy Trust helping men with the symptoms and treatments for Prostate Cancer, in the UK.

ABS - About Brachytherapy: About Prostate Cancer
According to the American Cancer Society, prostate cancer is one of the most common forms of cancer among American men, mainly affecting men over the age of

Prostate High Dose Rate (HDR) Brachytherapy
Prostate cancer is the model cancer for brachytherapy. The prostate gland is located under the bladder and in front of the rectum, and it is vital that the

Low dose rate brachytherapy for localised prostate cancer
Metastatic prostate cancer is usually treated with hormone therapy. Brachytherapy is a form of radiotherapy in which delivery of radiation is targeted

High dose rate brachytherapy for prostate cancer
IPG174 High dose rate brachytherapy for prostate cancer - guidance, 24 May 2006. IPG174 High dose rate brachytherapy for prostate cancer - information for

Internal radiotherapy for prostate cancer
You may hear your doctor call this brachytherapy. There are two types of brachytherapy - low dose rate and high dose rate. Both treat prostate cancer with

Prostate Cancer Treatment- Brachytherapy
Brachytherapy is the term used to describe two procedures used to irradiate prostate cancer tumors with lethal radiation. Is brachytherapy right for your

Prostate Cancer - All About Prostate Cancer
Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. (abstract)

The prostate, prostate cancer and brachytherapy by Mr Stephen
The prostate, prostate cancer and brachytherapy by Mr Stepehn Langley, a Prostate Specialist.

Brachytherapy for Prostate Cancer on Doherty
Below are all the very explicit details of my prostate cancer treatment by Dr. Michael Dattoli in Tampa, Florida using conformal 3-D external radiation

eMedicine - Prostate Cancer: Brachytherapy (Radioactive Seed
Prostate Cancer: Brachytherapy (Radioactive Seed Implantation Therapy) - Currently, the potentially curative treatment modalities offered to patients with

Prostate Cancer Treatment - Brachytherapy
*12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients with Clinically Localized Prostate Cancer. Louis Potters, et al.

Brachytherapy | Prostate Cancer Information | UPMC Cancer Centers
In a 1997 study of men with stage T1 or T2 prostate cancer who had received brachytherapy, the 7-year actuarial (statistically estimated) disease-free


brachytherapy cancer prostate
estrogen prostate cancer
cancer diet prostate
e prostate stim
cancer emedicine prostate